Benefits of long-acting β2-agonists -: Reply

被引：0
|
作者：
Gibson, Peter G. [1 ]
Ducharme, Francine M.
Cates, Christopher Joseph
机构：
[1] John Hunter Hosp, Newcastle, NSW, Australia
[2] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada
[3] St Georges Univ London, London, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2007年 / 120卷 / 03期
关键词：
D O I：
10.1016/j.jaci.2007.04.043
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：726 / 726
页数：1
相关论文
共 50 条
  • [21] Excess mortality in patients with asthma on long-acting β2-agonists
    Hasford, J.
    Virchow, J. C.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (05) : 900 - 902
  • [22] Long-acting β2-agonists in the treatment of acute exacerbations of COPD
    Cazzola, M
    Matera, MG
    D'Amato, M
    Noschese, P
    Califano, C
    Di Perna, F
    Terzano, C
    D'Amato, G
    CLINICAL DRUG INVESTIGATION, 2002, 22 (06) : 369 - 376
  • [23] Long-Acting β2-Agonists in the Treatment of Acute Exacerbations of COPD
    Mario Cazzola
    Maria G. Matera
    Maria D’Amato
    Paolo Noschese
    Clara Califano
    Felice Di Perna
    Claudio Terzano
    Gennaro D’Amato
    Clinical Drug Investigation, 2002, 22 : 369 - 376
  • [24] Long-acting β2-agonists:: the new symptom controllers for asthma
    Jenkins, CR
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 171 (05) : 255 - 258
  • [25] Safety of long-acting β2-agonists: current state of knowledge
    Jaeschke, Roman
    O'Byrne, Paul
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (11): : 912 - 913
  • [26] Safety of long-acting β2-agonists: a little bit of history
    Jaeschke, Roman
    O'Byrne, Paul
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (11): : 910 - 911
  • [27] Benefit-Risk Assessment of Long-Acting β2-Agonists in Asthma
    Catherine M. Jackson
    Brian Lipworth
    Drug Safety, 2004, 27 : 243 - 270
  • [28] The effect of long-acting β2-agonists on airway inflammation in asthmatic patients
    Howarth, PH
    Beckett, P
    Dahl, R
    RESPIRATORY MEDICINE, 2000, 94 : S22 - S25
  • [29] Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed
    Glenn A. Jacobson
    Sharanne Raidal
    Morten Hostrup
    Luigino Calzetta
    Richard Wood-Baker
    Mark O. Farber
    Clive P. Page
    E. Haydn Walters
    Drug Safety, 2018, 41 : 441 - 449
  • [30] Benefit-risk assessment of long-acting β2-agonists in asthma
    Jackson, CM
    Lipworth, B
    DRUG SAFETY, 2004, 27 (04) : 243 - 270
12345